The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
NCT Number: NCT05496439
Study of the prognosis of patients with heart failure with preserved ejection fraction
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chongqing, China
Obesity is an independent risk factor for heart failure with preserved ejection fraction (HFpEF), however, the impact of visceral fat area (VFA) in patients with HFpEF is unclear. According to established process of patients' selection, a total of 172 patients whose mean age was 72 years were included in this study, and the median follow-up duration was 395.5 days(interquartile range: 207.5 to 535.5 days). All patients were divided into two groups based on the best cut-off value of VFA, and the primary outcome of this study was all-cause death in patients with HFpEF. The aim of this study was to clarify whether VFA has prognostic value in patients with HFpEF by Kaplan-Meier analysis and cox analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1)left ventricular ejection fraction ≥50%; 2)with the symptoms and/or signs of heart failure; 3)BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL; 4)at least one additional criterion: relevant structural heart disease(LVH and/or LAE) or diastolic dysfunction
Exclusion criteria
Time frame: The median follow-up time of 395.5 days(interquartile range: 207.5 to 535.5 days)
all-cause death
Chongqing Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887271
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT06576297
Aging, Frailty
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04945707
Anemia, Anemia, Hypochromic
Boston, Massachusetts, United States
View Trial DetailsNCT07599293
Chronic Heart Failure, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details